Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Health Research Board, Ireland
Information provided by:
Makerere University
ClinicalTrials.gov Identifier:
NCT00620438
First received: February 7, 2008
Last updated: December 3, 2010
Last verified: December 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2011
  Estimated Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):